Atlas Trials

A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.

Clinical trial NCT03303521 · COMPLETED

Trial details

NCT number
NCT03303521
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperkalemia
Start date
2017-12-14
Primary completion
2018-11-07
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.